Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate

Journal of Attention Disorders

Volumn 16, Issue 5, 2012, Pages 384-397

  Katic, Alain ^a   Ginsberg, Lawrence ^b   Jain, Rakesh ^c   Adeyi, Ben ^d   Dirks, Bryan ^d   Babcock, Thomas ^d   Scheckner, Brian ^d   Richards, Cynthia ^d   Lasser, Robert ^d   Turgay, Atilla ^e   Findling, Robert L ^f  

^a Claghorn Lesem Research Clinic   (United States)

^b Red Oak Psychiatry Associates   (United States)

^c R/D Clinical Research Inc   (United States)

^d SHIRE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

ADHD; emotional lability; LDX; Lisdexamfetamine dimesylate; stimulant

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; LISDEXAMFETAMINE;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; EMOTION; FEMALE; HUMAN; MALE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMOTIONS; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 84864812998     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054710389990     Document Type: Article

References (31)

1. Ahmann P. A.,Waltonen S. J.,Olson K. A.,Theye F. W.,Van Erem A. J.,LaPlant R. J.Placebo-controlled evaluation of Ritalin side effects.Pediatrics. 1993;91:1101-1106.
2. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder.Pediatrics. 2001;108:1033-1044.
3. Diagnostic and statistical manual of mental disorders. 2000a). Oppositional defiant disorder. In Diagnostic and statistical manual of mental disorders (4th ed., text rev., pp 100-102). Washington, DC: Author.Washington, DC: Author; 2000a:100-102.
4. Diagnostic and statistical manual of mental disorders. 2000b). Attention-deficit and disruptive behavior disorders. In Diagnostic and statistical manual of mental disorders (4th ed., text rev., pp 85-93). Washington, DC: Author.Washington, DC: Author; 2000b:85-93.
5. Bauermeister J. J.,Shrout P. E.,Ramirez R.,Bravo M.,Alegria M.,Martinez-Taboas A., Canino G.ADHD correlates, comorbidity, and impairment in community and treated samples of children and adolescents.Journal of Abnormal Child Psychology. 2007;35:883-898.
6. Biederman J.,Boellner S. W.,Childress A.,Lopez F. A.,Krishnan S.,Zhang Y.Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study.Biological Psychiatry. 2007;62:970-976.
7. Biederman J.,Faraone S.,Milberger S.,Guite J.,Mick E.,Chen L., Perrin J.A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.Archives of General Psychiatry. 1996;53:437-446.
8. Biederman J.,Krishnan S.,Zhang Y.,McGough J. J.,Findling R. L.Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.Clinical Therapeutics. 2007;29:450-463.
9. Biederman J.,Lopez F. A.,Boellner S. W.,Chandler M. C.A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder.Pediatrics. 2002;110:258-266.
10. Carlson G. A.,Kelly K. L.Stimulant rebound: How common is it and what does it mean?.Journal of Child and Adolescent Psychopharmacology. 2003;13:137-142.
11. Findling R. L.,Bukstein O. G.,Melmed R. D.,Lopez F. A.,Sallee F. R.,Arnold L. E.,Pratt R. D.A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.Journal of Clinical Psychiatry. 2008;69:149-159.
12. Findling R. L.,Childress A. C.,Krishnan S.,McGough J. J.Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.CNS Spectrums. 2008;13:614-620.
13. Findling R. L.,Ginsberg L. D.,Jain R.,Gao J.Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: An open-label, dose-optimization study.Journal of Child and Adolescent Psychopharmacology. 2009;19:649-662.
14. Gillberg C.,Melander H.,von Knorring A.-L.,Janols L. O.,Thernlund G.,Hagglof B., Kopp S.Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.Archives of General Psychiatry. 1997;54:857-864.
15. Greenhill L.,Kollins S.,Abikoff H.,McCracken J.,Riddle M.,Swanson J., Cooper T.Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.Journal of the American Academy of Child & Adolescent Psychiatry. 2006;45:1284-1293.
16. Jacobson N. S.,Truax P.Clinical significance: A statistical approach to defining meaningful change in psychotherapy research.Journal of Consulting and Clinical Psychology. 1991;59:12-19.
17. Karpenko V.,Owens J. S.,Evangelista N. M.,Dodds C.Clinically significant symptom change in children with attention-deficit/hyperactivity disorder: Does it correspond with reliable improvement in functioning?.Journal of Clinical Psychology. 2009;65:76-93.
18. Kratochvil C. J.,Faries D.,Vaughan B.,Perwien A.,Busner J.,Saylor K., Swindle R.Emotional expression during attention-deficit/hyperactivity disorders treatment: Initial assessment of treatment effects.Journal of Child and Adolescent Psychopharmacology. 2007;17:51-62.
19. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD.Archives of General Psychiatry. 1999;56:1073-1086.
20. Pennick M.Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine.Neuropsychiatric Disease and Treatment. 2010;6:317-327.
21. Perwien A. R.,Kratochvil C. J.,Faries D.,Vaughan B.,Busner J.,Saylor K. E., Swindle R.Emotional expression in children treated with ADHD medication: Development of a new measure.Journal of Attention Disorders. 2008;11:568-579.
22. Short E. J.,Manos M. J.,Findling R. L.,Schubel E. A.A prospective study of stimulant response in preschool children: Insights from ROC analyses.Journal of the American Academy of Child & Adolescent Psychiatry. 2004;43:251-259.
23. Silva R. R.,Muniz R.,Pestreich L.,Childress A.,Brams M.,Lopez F. A.,Wang J.Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder.Journal of Child and Adolescent Psychopharmacology. 2006;16:239-251.
24. Spencer T. J.,Wilens T. E.,Biederman J.,Weisler R. H.,Read S. C.,Pratt R.Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study.Clinical Therapeutics. 2006;28:266-279.
25. Strine T. W.,Lesesne C. A.,Okoro C. A.,McGuire L. C.,Chapman D. P.,Balluz L. S.,Mokdad A. H.Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention- deficit/hyperactivity disorder.Preventing Chronic Disease. 2006;3:A52.
26. Swanson J.,Gupta S.,Guinta D.,Flynn D.,Agler D.,Lerner M., Wigal S.Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.Clinical Pharmacology and Therapeutics. 1999;66:295-305.
27. Whalen C. K.,Henker B.,Granger D. A.Ratings of medication effects in hyperactive children: Viable or vulnerable?.Behavioral Assessment. 1989;11:179-199.
28. Wigal S. B.,Kollins S. H.,Childress A. C.,Squires L.A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.Child and Adolescent Psychiatry and Mental Health. 2009;3:17.
29. Wigal T.,Greenhill L.,Chuang S.,McGough J.,Vitiello B.,Skrobala A.,Stehli A.Safety and tolerability of methylphenidate in preschool children with ADHD.Journal of the American Academy of Child & Adolescent Psychiatry. 2006;45:1294-1303.
30. Wilens T. E.,McBurnett K.,Bukstein O.,McGough J.,Greenhill L.,Lerner M., Lynch J. M.Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.Archives of Pediatric & Adolescent Medicine. 2006;160:82-90.
31. Wyrwich K. W.,Tierney W. M.,Wolinsky F. D.Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.Journal of Clinical Epidemiology. 1999;52:861-873.